Incidence and Predictors of Febrile Neutropenia among Early-Stage Breast Cancer Patients Receiving Anthracycline-Based Chemotherapy in Korea

Publisher： Karger

E-ISSN： 1423-0232|91|5|274-282

ISSN： 0030-2414

Source： Oncology, Vol.91, Iss.5, 2016-09, pp. : 274-282

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic Significance of Neutropenia on Day One of Anthracycline-Based Neoadjuvant Chemotherapy in Operable Breast Cancer

By  

Oncology, Vol. 78, Iss. 3-4, 2010-04 ,pp. : 213-219

Karger

Access to resources Recommend Favorite

G-CSF in the Prevention of Febrile Neutropenia in Chemotherapy in Breast Cancer Patients

By  

Oncology Research and Treatment, Vol. 29, Iss. 4, 2006-03 ,pp. : 171-178

Karger

Access to resources Recommend Favorite

Comparison of Actual Hospital Costs versus DRG Revenues for In-Patient Treatment of Febrile Neutropenia during Adjuvant Anthracycline plus/minus Taxane-Based Chemotherapy for Primary Breast Cancer

By  

Oncology Research and Treatment, Vol. 34, Iss. 11, 2011-10 ,pp. : 614-618

Karger

Access to resources Recommend Favorite

Diastolic dysfunction common among breast cancer patients receiving anthracycline

By  

CANCER, Vol. 121, Iss. 20, 2015-10 ,pp. : 3563-3563

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tumor Topoisomerase II Alpha Status and Response to Anthracycline-Based Neoadjuvant Chemotherapy in Breast Cancer

By  

Oncology, Vol. 80, Iss. 3-4, 2011-07 ,pp. : 269-277

Karger

Access to resources Recommend Favorite